¡Activa las notificaciones laborales por email!
Mejora tus posibilidades de llegar a la entrevista
The University of Granada invites postdoctoral candidates to apply for a Marie Skłodowska-Curie Postdoctoral Fellowship. This opportunity involves research in drug design, organic synthesis, and biological screening, aimed at developing new drugs to combat metabolic diseases. Successful candidates will gain experience published in reputable journals.
Department of Medicinal Chemistry and Organic Chemistry
Organisation / Company: University of Granada
Department: International Research Projects Office
Laboratory: Department of Medicinal Chemistry and Organic Chemistry
Is the Hosting related to staff position within a Research Infrastructure? No
Professor Mónica Díaz Gavilán from the Department of Medicinal Chemistry and Organic Chemistry at the University of Granada welcomes postdoctoral candidates interested in applying for a Marie Skłodowska-Curie Postdoctoral Fellowship (MSCA-PF) in 2025 at this university. Applicants must comply with the Mobility Rule (more info about the 2025 call can be found here).
The University of Granada (UGR), founded in 1531, is one of Spain's largest and most prestigious universities, with approximately 54,000 students and over 6,000 staff members. It offers a wide range of undergraduate, master's, and doctoral programs across its numerous departments and centers. UGR is recognized for its research excellence, ranking among the top Spanish universities in various metrics, including international rankings like ARWU, where it is positioned between 301-400 globally and 3-8 in Spain.
The university has received the 'Human Resources Excellence in Research' award and has been successful in securing numerous research projects under EU frameworks like Horizon 2020 and Horizon Europe, with significant funding.
The research group comprises three lecturers and two postdoctoral researchers focusing on drug design, organic synthesis, and biological screening. The facilities include advanced equipment for organic synthesis and in silico drug design, and collaborations with several international researchers.
The project aims to develop small molecule drugs to inhibit oxalate biosynthesis, addressing severe metabolic diseases such as primary hyperoxalurias and MASH. The candidate will participate in molecule design, synthesis, characterization, biological screening, and testing in cell models, gaining skills in drug development. Results will be published in high-impact journals and presented at international conferences.
Interested candidates should send their documents to Professor Mónica Díaz Gavilán at monicadg@ugr.es.